What we do—

Changing the world

UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.

Read More
Latest news—

Syncona brings together leading experts in Treg Research for the formation of Quell Therapeutics

Today Syncona announced the foundation of Quell Therapeutics (Quell), a new cell therapy company, with a £35 million commitment in a Series A financing of which £1 million will be invested in syndicate by UCL Technology Fund. Funds will be tranched in three phases with Syncona acquiring a 69.3 per cent stake in the business upon third tranche completion.

Read More
Featured Technology—

Novel method of analysis of stroke data

Stroke is the leading cause of adult disability in the UK at an estimated cost of £7 billion a year. UCL has developed a system for predicting clinical outcomes so as to provide advance information on the optimum clinical management of each patient.
Read more
Spotlight—

How does Portico Ventures support non-patentable and fast-to-deploy technologies?

As Portico Ventures is well under way at UCL, we catch up with Programme Manager Denisa Naidin on how UCLB’s work is helping to speed up the route to commercialisation for Computer Science innovations at UCL.

Read More
Featured Technology—

SnakeGrid

SnakeGrid is a way of developing low-distortion coordinate systems for large engineering projects.

Read more

Latest news and highlights

Read More News

Syncona brings together leading experts in Treg Research for the formation of Quell Therapeutics

/ UCLB News
Today Syncona announced the foundation of Quell Therapeutics (Quell), a new cell therapy company, with a £35 million commitment in ...

Using space technology to fight bowel cancer

/ UCLB News
Portico Ventures Programme spinout Odin Vision, which is using space technology to improve the early detection and diagnosis of bowel ...

Annual Review UCLB’s 25th Year

/ Annual Reports, UCLB News
Download the UCLB Annual Review as a PDF ...

Autolus Therapeutics Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019

/ UCLB News
Conference Call and Webcast to Be Held Tuesday, April 2, 2019 at 8:00 am ET / 1:00 pm BST UCLB ...

FIND THE RIGHT MATCH

Whether you’re an academic or looking for technologies, find your UCLB contact here.

 

Bringing innovation to life

0
Active spinouts
0
Active licences in 2018
0
Drug discoveries
0
New patent applications